Therapeutic approaches to target inflammation in type 2 diabetes
- PMID: 21098138
- PMCID: PMC3227024
- DOI: 10.1373/clinchem.2010.148833
Therapeutic approaches to target inflammation in type 2 diabetes
Abstract
Background: Chronic inflammation may participate in the pathogenesis of insulin resistance, type 2 diabetes, and cardiovascular disease and may be a common denominator that links obesity to these disease states.
Content: Epidemiologic studies have linked inflammatory biomarkers to incident diabetes and cardiovascular disease risk. Cellular and animal studies have provided support to the idea that inflammation mediates these disease processes, providing impetus to pharmacologically target these pathways for disease treatment and prevention. We review clinical strategies to target inflammation, with a focus on the antiinflammatory and antihyperglycemic effects of salicylates.
Summary: The evolving concept of diet-induced obesity driving insulin resistance, type 2 diabetes, and cardiovascular disease through immunologic processes provides new opportunities for the use of antiinflammatory strategies to correct the metabolic consequences of excess adiposity.
Conflict of interest statement
Figures
References
-
- Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:455–61. - PubMed
-
- Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC- Norfolk Prospective Population Study. J Intern Med. 2007;262:678–89. - PubMed
-
- Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–34. - PubMed
-
- Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M, Koenig W. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984–1998. Arch Intern Med. 2003;163:93–9. - PubMed
-
- Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR002635/RR/NCRR NIH HHS/United States
- R01 DK045943/DK/NIDDK NIH HHS/United States
- P50 HL083813/HL/NHLBI NIH HHS/United States
- RC4 DK090792/DK/NIDDK NIH HHS/United States
- R01 DK051729/DK/NIDDK NIH HHS/United States
- R01 DK073547/DK/NIDDK NIH HHS/United States
- R37 DK051729/DK/NIDDK NIH HHS/United States
- U01 DK074556/DK/NIDDK NIH HHS/United States
- U01DK074556/DK/NIDDK NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
- M01 RR001032/RR/NCRR NIH HHS/United States
- R01 HL091750/HL/NHLBI NIH HHS/United States
- R01HL091750/HL/NHLBI NIH HHS/United States
- P50HL083813/HL/NHLBI NIH HHS/United States
- P30DK036836/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
